SLC5A1 and hypertrophic cardiomyopathy: Hirose et al. demonstrated that knock-out of SGLT1 alleviates pressure overload-induced cardiomyopathy, suggesting that SGLT1 inhibitors have an active effect on hypertrophic cardiomyopathy (Hirose, 2018).